Prognostic Biomarkers for Gynecologic Cancers: Future Directions
Received Date: Oct 01, 2025 / Published Date: Oct 29, 2025
Abstract
Prognostic biomarkers are essential for personalizing treatment and improving outcomes in gynecologic cancers. Research focuses on molecular markers, ctDNA, TILs, molecular subtypes, HPV status, multi-omics, radiomics, microbiome, and epigenetic modifications. Machine learning aids in biomarker discovery, leading to more accurate prognostic models for tailored patient care
Citation: Allen DJ (2025) Prognostic Biomarkers for Gynecologic Cancers: Future Directions. Current Trends Gynecol Oncol 10: 297
Copyright: 漏 2025 Dr. James Allen This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 213
- [From(publication date): 0-0 - Apr 06, 2026]
- Breakdown by view type
- HTML page views: 167
- PDF downloads: 46
